Children's Acetaminophen Suspension Recalled for Manufacturing Defect
Perrigo Company is recalling Children's Pain and Fever (Acetaminophen) oral suspension due to use of contaminated excipient during manufacturing. The product was distributed nationwide in the United States.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall. The source text does not report any illnesses, injuries, or deaths, and the hazard described—use of contaminated excipient—is a manufacturing deviation. No specific illness or injury risk is detailed in the source, making this a precautionary recall consistent with Moderate severity.
Plain-English summary
Perrigo Company PLC is recalling Children's Pain and Fever (Acetaminophen) Dye Free Cherry Flavor Oral Suspension, 160mg/5ml, 4 FL OZ (118 mL) bottles nationwide in the United States. The product carries NDC 30142-818-26 and batch 1BK1045 with expiration date 12/31/2022. A total of 3,120 bottles were distributed.
The recall was issued because the products were manufactured with a contaminated excipient that had been recalled from the excipient supplier. This represents a deviation from current Good Manufacturing Practice (CGMP) standards.
Consumers who have purchased this product should stop use and consult with a healthcare provider if they have any questions or concerns about its safety or use.
The recalled product
- Product
- CHILDRENS PAIN AND FEVER (ACETAMINOPHEN)
- Brand
- CHILDRENS PAIN AND FEVER
- Manufacturer
- Perrigo Company PLC
- Hazard
- manufacturing-defect
- contaminated-excipient
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1BK1045
- Exp 12/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CHILDRENS PAIN AND FEVER
- ModerateChildren's Acetaminophen Oral Suspension Recall due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27